Found 9 results for express

ExpressJet Custom Deal Toy

Custom deal toy recognizing the acquisition of ExpressJet by SkyWest, headquartered in St. George, Utah. Atlanta-based ExpressJet was advised in the deal by Goldman Sachs

1 Image

Arla Foods and Express Custom Lucite

Custom Lucite celebrating the merger of Express and Arla Foods, two dairies based in the United Kingdom.

1 Image

Lucite Tombstone for Cross-Border Banking Deal

Lucite tombstone commemorating the acquisition of a stake in Bank Metro Express by South Korea’s Shinhan Bank. Bank Metro Express is commercial lender based in Jakarta, Indonesia.

(5HST627)
1 Image

Acrylic Paperweights: Are They Really What You Want?

November 22, 2021 by David Parry

The term “acrylic paperweight” is a common one, but it’s also something of a misnomer. In our...

 Blog Post

Toll Road-Themed Deal Toy

Custom deal toy involving 183 South toll road project, aimed at improving access to the Austin-Bergstrom International Airport in Texas. The first phase of the project—known popularly as the Bergstrom Expressway—is due to be completed in 2019.

( 6AKL785)
1 Image

Trading Floor-Themed Deal Tombstone

Crystal trading floor-themed deal tombstone marking the initial public offering (IPO) of SG Holdings. A Japanese logistics company, SG is also the parent of Sagawa Express, the country’s second-largest package delivery firm.

(7ALJ879)
1 Image

5 Important Company Milestones And How To Celebrate Them

September 20, 2021 by David Parry

Celebrating company milestones is a great way to maintain morale at your organization. After all,...

 Blog Post

Deal Tombstones: 5 Ways to Magnify Their Marketing Impact

February 9, 2024 by David Parry

If may be new to deal tombstones or, as they're also more commonly known, "deal toys". To the...

 Blog Post

DNA Strand-Inspired Licensing Commemorative

Lucite commemorative celebrating a development and commercialization agreement between Takeda and Arrowhead Pharmaceuticals.

(21ALJ357)
2 Images
Custom Lucite commemorating a development and commercialization agreement between Japanese drug maker Takeda and California-based Arrowhead Pharmaceuticals. The agreement centers on drugs that treat disease by using RNA to block gene expression.